Ramot at Tel Aviv University Ltd.
Division of Tel Aviv University
Latest From Ramot at Tel Aviv University Ltd.
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in July and August 2017.
Jerusalem-based BioLineRx has signed a worldwide, exclusive licence agreement with Ramot, the technology transfer arm of Tel Aviv University, in order to gain access to the early-stage compound BL-7050, an orally available molecule for neuropathic and inflammatory pain. Financial terms were not disclosed.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.